Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective
Main Authors: | Jorge Magdaleno-Tapial, PhD, Pablo Hernández-Bel, PhD, Altea Esteve-Martínez, PhD, Rodrigo Peñuelas-Leal, MD, Carolina Labrandero-Hoyos, MD, José Luis Sánchez-Carazo, PhD, Amparo Pérez-Ferriols, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235251262400064X |
Similar Items
-
Efficacy of autologous melanocytic transplantation by flip-top technique in patients of stable vitiligo
by: Jyoti Budhwar, et al.
Published: (2022-01-01) -
Efficacy of suction blister epidermal graft without phototherapy for locally stable and resistant vitiligo
by: Masoud Maleki, et al.
Published: (2012-01-01) -
Amelioration of unstable vitiligo and normalization of thryroglobulin antibodies with oral tofacitinib
by: Angela Yen Moore, MD, et al.
Published: (2022-05-01) -
Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
by: David Nash, BHSc, et al.
Published: (2023-02-01) -
GLUTEN-FREE DIET – POSSIBLE THERAPEUTIC APPROACH TO VITILIGO
by: Ana Maria Alexandra Stănescu, et al.
Published: (2018-12-01)